Clinical Trial: Fluvoxamine for Long COVID-19
Study Status: Completed
Recruit Status: RECRUITING
Condition: Long COVID
Study Type: INTERVENTIONAL
Official Title: FLUVOXAMINE AS A TREATMENT FOR LONG COVID-19: A RANDOMIZED PLACEBO CONTROLLED TRIAL
Brief Summary:
This clinical trial aims to test the effects of fluvoxamine as a treatment for Long COVID.Fluvoxamine is an FDA approved SSRI for Obsessive Compulsive Disorder (OCD), that has already had success in preventing hospitalization in patients with COVID-19 (STOP COVID and TOGETHER trials).This trial is testing whether fluoxamine helps to improve symptoms and the negative impacts of long COVID in residents of Missouri and Illinois.
Read more